BoxOne Ventures

Stately Bio is a biotechnology company that specializes in live-cell imaging technology. It utilizes patented machine learning methods to analyze cell identity, behavior, and maturation without the need for labels, allowing for real-time observation of living cells. By focusing on the balance between accurate measurement and cellular viability, Stately Bio aims to advance research and applications in cellular biology. Currently, the company operates in stealth mode, suggesting that it is in the early stages of development and may be preparing for future product launches or partnerships.

Dispersa is a company dedicated to developing environmentally friendly biosurfactants derived from food waste. Unlike traditional surfactants that rely on palm oil or petroleum, Dispersa utilizes microbes to create surfactants that are both sustainable and circular in nature. These biosurfactants excel at dispersing oil particles by enveloping them in micelles, facilitating their breakdown and removal. By providing a sustainable alternative to synthetic and petroleum-based surfactants, Dispersa aims to enhance the sustainability and affordability of the biosurfactant market, offering industry users access to environmentally responsible products for the first time globally.

CytoTronics is focused on designing and developing advanced cell culture plates that incorporate embedded high-density electronic systems. This innovative technology enables researchers to visualize live cell functions on a large scale and obtain real-time data on cell behavior. By facilitating detailed studies of complex biological processes, CytoTronics aims to support significant advancements in fields such as drug discovery and personalized medicine. The company's semiconductor-based systems provide a valuable tool for researchers, enhancing their ability to investigate cellular dynamics and improve the understanding of cellular interactions.

Talus Bio is a biotechnology startup focused on drug discovery and development, particularly targeting challenging cancer transcription factors. The company employs an innovative approach that integrates functional proteomics, automated biology, and machine learning. Their MARMOT platform utilizes AI, advanced proteomics, synthetic chemistry, and computational biology to design and analyze drugs, proteins, and genomics. This platform is designed to advance drug development for gene regulation in oncology, aiming to create small-molecule therapies that can effectively control gene expression in cancer cells.

Opalia is a manufacturer specializing in the production of milk and milk ingredients derived from mammary cells, aimed at providing an alternative to traditional cow milk. Utilizing advanced technology, the company creates real milk without the use of cows, ensuring that the final product retains the performance, taste, and nutritional profile comparable to or exceeding that of conventional dairy. By focusing on sustainability and ethical production methods, Opalia seeks to offer consumers a viable and innovative option in dairy products, addressing the growing demand for alternatives to traditional dairy.

Pathway is a health technology company focused on enhancing access to essential medical information for clinicians and patients during the care journey. The company develops a point-of-care reference tool that provides rapid access to evidence-based clinical guidelines. By organizing and condensing medical literature, Pathway aims to make critical information more accessible and easier to understand for healthcare professionals. This approach enables clinicians to work more efficiently, ultimately improving patient outcomes. Leveraging artificial intelligence and big data, Pathway creates a medical knowledge graph and software solutions that integrate evidence-based medicine into clinical practice.

BioLoomics, Inc. is a biotechnology company based in Boulder, Colorado, founded in 2019. It specializes in drug screening services that assess drug action and toxicity by profiling drug effects in live cells using advanced biosensor technology. The company employs directed evolution to develop antibodies with programmable spatial fate in target cells, enhancing the precision of drug discovery. BioLoomics utilizes high-throughput multiplexed profiling to analyze biochemical events in mammalian cells, screening chemical libraries and complex mixtures to identify unique cellular responses. This innovative approach enables clients to improve the success rate and reduce the costs associated with drug development, making significant contributions to the field of synthetic biology and live-cell imaging.

Vivid Machines is a startup focused on enhancing agricultural production for fruit and vegetable farmers. The company leverages advanced vision sensors and machine learning to deliver plant-specific insights, capturing previously unobserved features that improve yield and product quality. Its technology enables farmers to digitize the physical and chemical properties of their fields, facilitating more informed decision-making and increasing the percentage of crops that reach grocery stores. Vivid Machines' system quantifies fruit size distribution, detects pests and diseases, and evaluates overall plant conditions in real-time. By integrating seamlessly into existing workflows, the company's solution provides critical data that helps optimize the fruit supply chain for growers, pack houses, and marketers.

Nimble Science Ltd. is a digital health company focused on revolutionizing gastrointestinal (GI) health through its innovative SIMBA capsule technology. This end-to-end platform facilitates multi-omic mapping of the GI tract, allowing for the passive sampling of small bowel luminal fluid. By leveraging this advanced sampling method, Nimble Science provides precision datasets that offer valuable insights into GI health, thereby transforming the diagnosis and treatment of gastrointestinal conditions. The company's approach enables healthcare providers to directly sample and analyze targeted regions of the GI tract, marking a significant advancement in the understanding and management of GI health.

Magnestar is a technology company focused on enhancing communication between Earth and space by predicting and mitigating communication outages. It employs a skilled team to develop both software and hardware solutions that facilitate the monitoring of signal communication in outer space. Magnestar's platform enables users to conduct interference simulations, both short-term and long-term, and integrates these simulations within a collaborative infrastructure to streamline coordination processes. The company provides near real-time monitoring of the spectrum environment, ensuring compliance and effective communication between satellite and Earth systems. By equipping assets with its advanced technology, Magnestar aims to improve their longevity and service quality, ultimately enhancing safety in space and fostering reliable space services for future explorations.

Odd Burger is a plant-based food technology company that specializes in producing and distributing plant-based protein and dairy alternatives. Established in 2014 and originally known as Globally Local, the company initially focused on offering delivery services for food boxes and plant-based produce. Odd Burger aims to make plant-based foods accessible and affordable, promoting better health, environmental sustainability, and animal welfare. It operates a manufacturing facility and distributes its products through a proprietary food service line to both company-owned and franchised fast-food restaurant locations. These locations function as smart kitchens, utilizing advanced cooking technology and automation to provide a satisfying dining experience for customers seeking healthier and more sustainable fast food options. Odd Burger is committed to using locally sourced and sustainable ingredients in its offerings.

Seqera is a developer of workflow orchestration software that simplifies complex data analysis pipelines for life sciences research. The company's platform consolidates fragmented data and computing resources, allowing scientists to efficiently assemble and deploy scalable data analysis pipelines across multi-cloud environments. This capability enables researchers to tackle complex problems in genomics and global health, enhancing productivity and accelerating the pace of discovery. Trusted by over 150 leading organizations in the life sciences sector, Seqera's software empowers scientists to work with larger datasets and complete their analyses more quickly and confidently. Through its innovative approach, Seqera drives advancements in research and fosters collaboration within the scientific community.

Wayfinder Biosciences is a biotechnology company focused on developing orally available small molecule drugs that target RNA to address key disease areas, including oncology and neurodegenerative disorders. Established in 2021 and headquartered in Seattle, WA, the company utilizes a proprietary platform that integrates advanced screening technologies and computational methods to discover potent and selective RNA-targeting molecules. By employing high-throughput screening combined with machine learning and unique datasets, Wayfinder aims to accelerate the development of therapeutics for traditionally inaccessible targets, enhancing the potential for treating genetic diseases and other challenging conditions.

Covey is an analyst-led community focused on identifying and rewarding emerging talent in money management. The company has developed a financial platform that facilitates the creation and sharing of portfolios among users. This platform allows analysts to share portfolio analytics across various communities while aggregating trade-level data on equities. By providing a sophisticated mock portfolio trading suite, Covey assists hedge funds and investment institutions in refining their trading strategies, ultimately enhancing their investment decision-making processes.

Spiderwort is an innovative company based in Ottawa, Ontario, founded in 2015, focused on developing biomaterials for regenerative medicine. The company specializes in creating cellulose-based biomaterials that serve as living scaffolds, which can be utilized for various medical applications, including spinal cord injury repair and soft tissue regeneration. Spiderwort's products encompass a range of biological and synthetic polymers available in multiple forms, such as powders, gels, membranes, and pastes. Currently in the pre-clinical stage, their novel biomaterials have shown promising results in terms of biocompatibility and the ability to induce angiogenesis, which is the generation of blood vessels within the scaffold. This approach aims to advance the repair and regeneration of tissues within the human body, providing new solutions for challenging medical conditions.

Unravel Biosciences is a therapeutics company that originated from the Wyss Institute at Harvard University, focusing on developing innovative treatments for complex disorders. The company utilizes a proprietary AI-powered discovery engine that integrates a large-scale model of human health with rapid in vivo screening and clinical validation to identify and validate new drug targets. By leveraging existing drugs, Unravel aims to expedite the clinical development process, achieving results 2-3 times faster and more cost-effectively than traditional methods. The platform has successfully facilitated discoveries that are now advancing into four clinical trials. Additionally, Unravel has established partnerships through its rareSHIFT services, contributing to a robust therapeutics pipeline, an expanding intellectual property portfolio, and an increase in clinical samples, all while maintaining profitability.

Isabl is a startup focused on developing advanced diagnostic assays for cancer through whole-genome and RNA sequencing. Founded in 2020 after incubating its technology at Memorial Sloan Kettering Cancer Center from 2015 to 2019, Isabl participated in the Winter 2020 batch of Y Combinator and has attracted significant funding, including a $3 million seed round and a $2 million SBIR grant from the National Cancer Institute. The company received FDA Breakthrough Device designation in 2021, recognizing the innovative nature of its cancer diagnostic tests. Isabl's platform is designed to efficiently analyze cancer patients' genomes while ensuring data reproducibility and supporting bioinformatics operations, thereby facilitating data-driven automation for oncology centers. Led by founders Dr. Elli Papaemmanuil, Dr. Andrew Kung, and Juan Medina, Isabl's team combines expertise in precision medicine, computational biology, and software engineering, focusing on biomarker discovery and clinical decision support for pediatric and rare solid cancers.

SX Network operates a blockchain-based sports betting exchange, offering bettors improved odds, transparency, and secure fund management through smart contract technology. Its platform integrates an on-chain community treasury and native prediction market protocol, facilitating decentralized sports betting markets governed by users via prediction market-based governance.

DrugBank is a developer of a comprehensive drug knowledge platform aimed at enhancing healthcare delivery and accelerating drug research. Their robust database provides extensive information on pharmaceuticals, including mechanisms of action, drug interactions, and allergy information, which empowers healthcare professionals to make informed decisions. The platform includes tools for drug search, interaction checking, and access to drug labels, facilitating precision medicine and clinical software applications. By integrating these resources into various software solutions via their API, DrugBank enables companies to scale their usage and expedite the development of novel drug candidates and predictive machine learning models. Additionally, DrugBank Online offers a free-to-use resource with limited datasets for academic and non-commercial research, contributing to its recognition in over 13,000 academic publications and its widespread use among millions of researchers and health professionals worldwide.

Shakepay Inc. is a Montreal-based technology company that specializes in financial applications aimed at helping users build wealth through cryptocurrency. Founded in 2015, Shakepay offers a platform that allows Canadians to buy and sell Bitcoin, as well as a peer-to-peer mobile wallet for secure transactions. The company's services include a VISA debit card that enables users to load and spend Bitcoin for various purposes, including point of sale transactions, ATM withdrawals, and online purchases. By providing these innovative financial tools, Shakepay aims to facilitate the use of digital currencies in everyday transactions.

TriplePlay is a Toronto-based company founded in 2020 that offers a virtual social network designed to facilitate connections among users through interactive gaming and video-based communication. The platform allows individuals to engage in one-on-one or group conversations, participate in workshops, panel discussions, and live demonstrations, as well as enjoy games together. With features that support private conversations and customization options, TriplePlay aims to create a more natural and engaging social experience for its users.

Coinmiles is a developer of an advanced Bitcoin-based reward application that offers users cashback in the form of Bitcoin when shopping online or in-store at over 1,000 brands, as well as when traveling at more than 900,000 hotels worldwide. The platform aims to create a comprehensive ecosystem that not only rewards consumers but also assists brands in managing and advertising their loyalty programs. By facilitating partnerships between users and brands, Coinmiles enhances user acquisition and engagement, allowing shoppers to convert their Bitcoin rewards into cash as needed. The company continues to innovate and expand its offerings within the cryptocurrency reward space.

Pathway is a health technology company focused on enhancing access to essential medical information for clinicians and patients during the care journey. The company develops a point-of-care reference tool that provides rapid access to evidence-based clinical guidelines. By organizing and condensing medical literature, Pathway aims to make critical information more accessible and easier to understand for healthcare professionals. This approach enables clinicians to work more efficiently, ultimately improving patient outcomes. Leveraging artificial intelligence and big data, Pathway creates a medical knowledge graph and software solutions that integrate evidence-based medicine into clinical practice.

Seqera is a developer of workflow orchestration software that simplifies complex data analysis pipelines for life sciences research. The company's platform consolidates fragmented data and computing resources, allowing scientists to efficiently assemble and deploy scalable data analysis pipelines across multi-cloud environments. This capability enables researchers to tackle complex problems in genomics and global health, enhancing productivity and accelerating the pace of discovery. Trusted by over 150 leading organizations in the life sciences sector, Seqera's software empowers scientists to work with larger datasets and complete their analyses more quickly and confidently. Through its innovative approach, Seqera drives advancements in research and fosters collaboration within the scientific community.

Colabra is a technology company that specializes in enhancing the productivity of scientific teams by providing real-time collaboration tools, integrating diverse datasets, and offering agile project management solutions. Its platform enables scientists to track workflows, provide feedback, share data, and streamline research processes, thereby reducing inefficiencies and fostering innovation within scientific research and development teams.

Vivid Machines is a startup focused on enhancing agricultural production for fruit and vegetable farmers. The company leverages advanced vision sensors and machine learning to deliver plant-specific insights, capturing previously unobserved features that improve yield and product quality. Its technology enables farmers to digitize the physical and chemical properties of their fields, facilitating more informed decision-making and increasing the percentage of crops that reach grocery stores. Vivid Machines' system quantifies fruit size distribution, detects pests and diseases, and evaluates overall plant conditions in real-time. By integrating seamlessly into existing workflows, the company's solution provides critical data that helps optimize the fruit supply chain for growers, pack houses, and marketers.

Revelio Labs is a developer of a labor market analytics platform that provides comprehensive insights into global workforces. By leveraging advanced AI technologies, the company processes vast amounts of online profiles, resumes, and job postings to create a standardized database of public employment records. This platform offers valuable workforce analytics, allowing corporate strategists, HR professionals, venture capitalists, and investors to understand company and market dynamics, identify skill gaps, and make informed, data-driven decisions. Revelio Labs enables its clients to uncover trends in human capital, facilitating strategic workforce planning and optimization.

Axonis Therapeutics is a biotechnology company focused on developing therapies for neurological disorders by targeting the KCC2, a key mediator of inhibition in the brain. The company leverages groundbreaking research from institutions such as Boston Children’s Hospital, Harvard, and Laval University to create a proprietary neuron-specific K-Cl cotransporter discovery engine. This innovative platform aims to enhance the treatment of various conditions, including epilepsy, pain, and other central nervous system pathologies, by fine-tuning neuronal inhibition. Through its efforts, Axonis Therapeutics seeks to contribute to the healthcare industry's ability to combat neurodegeneration, restore neuronal excitation, and promote neuron regeneration, ultimately improving the quality of life for individuals affected by these disorders.

FabricNano Limited, founded in 2018 and headquartered in London, United Kingdom, specializes in cell-free biomanufacturing, focusing on the development of innovative biocatalysts and artificial cells. The company leverages advancements in nanotechnology and biotechnology to create designs and construction schematics for artificial cells that enhance the speed, purity, and adaptability of chemical reactions. By optimizing these processes, FabricNano enables businesses to streamline production workflows, eliminate capacity bottlenecks, and reduce associated costs, thereby unlocking new possibilities in the realm of biochemistry.

Giving superpowers to medical professionals by transforming messy medical data into useful insights.

Tornado operates a social investment discussion platform aimed at enhancing the skills and profitability of investors. The platform facilitates discussions among users and experts, allowing participants to share and learn investment ideas. By providing tools for portfolio allocation, Tornado enables users to make informed investment decisions tailored to their specific objectives. This approach transforms the investing experience into a more engaging and sophisticated process compared to traditional online brokerages. Tornado's focus on community-driven investment strategies aims to empower investors of all skill levels to improve their profitability and portfolio intelligence.

Kenota Health is a company that specializes in the development of advanced diagnostic tools for allergy testing in humans. Their innovative point-of-care system streamlines the allergy testing process by utilizing a small blood sample, which is analyzed through their equipment to detect allergen sensitization within minutes. This non-invasive technology not only simplifies the testing procedure but also provides timely results directly to healthcare providers, enhancing the overall quality of diagnostic information available to physicians. By offering a safer and more cost-effective alternative to traditional allergy testing methods, Kenota Health aims to improve patient outcomes and facilitate better healthcare decision-making.

Slingshot is a decentralized finance (DeFi) trading platform that enables users to buy, sell, swap, and bridge over 50,000 cryptocurrencies. Founded in 2018 and based in San Francisco, California, Slingshot offers a secure and user-friendly interface that combines the efficiency of centralized platforms with the transparency and security of decentralized technologies. The platform aggregates prices across multiple decentralized exchanges, ensuring users have access to the best available rates for their token trades. It features a range of tools, including live price charts, portfolio tracking, and various wallet integrations, all designed to enhance the trading experience. Renowned for its commitment to security and user sovereignty, Slingshot aims to empower retail users in the digital asset space.

PowerTrade is a mobile-based platform that specializes in crypto options and derivatives trading, allowing users to engage in options, futures, perpetuals, and hedging from a single interface. The platform is designed to deliver a user-friendly experience, focusing on simplicity and speed to cater to the needs of traders. By offering competitive pricing and lower margin requirements, PowerTrade aims to enhance return on investment for its users. Additionally, it provides a request for quote (RFQ) feature, which helps traders manage risks and secure favorable prices for larger and more complex trades. Overall, PowerTrade seeks to empower professional traders by optimizing profit opportunities while minimizing the risks associated with trading in the cryptocurrency market.

Injective Labs is a research and software development company that focuses on creating innovative decentralized finance solutions. It is a core contributor to Injective, a blockchain platform specifically designed for the finance sector. Injective operates as an open and interoperable network, enabling decentralized application developers to build on a foundation that is compatible with both Cosmos IBC and Ethereum. The platform offers unique benefits such as zero gas fees, secure transactions, and rapid data transmission, promoting dynamic scalability for its applications. By leveraging cryptographic research, Injective’s decentralized derivatives exchange protocol addresses significant security vulnerabilities and scaling challenges in decentralized exchanges. The overarching mission of Injective Labs is to foster a free and inclusive financial system through the principles of decentralization.

DrugBank is a developer of a comprehensive drug knowledge platform aimed at enhancing healthcare delivery and accelerating drug research. Their robust database provides extensive information on pharmaceuticals, including mechanisms of action, drug interactions, and allergy information, which empowers healthcare professionals to make informed decisions. The platform includes tools for drug search, interaction checking, and access to drug labels, facilitating precision medicine and clinical software applications. By integrating these resources into various software solutions via their API, DrugBank enables companies to scale their usage and expedite the development of novel drug candidates and predictive machine learning models. Additionally, DrugBank Online offers a free-to-use resource with limited datasets for academic and non-commercial research, contributing to its recognition in over 13,000 academic publications and its widespread use among millions of researchers and health professionals worldwide.

Sollum Technologies Inc., established in 2015 and headquartered in Montreal, Canada, specializes in designing and manufacturing innovative lighting systems. The company's core product is a smart LED lighting solution that dynamically replicates the full spectrum of natural sunlight, optimizing growth conditions for crops and animals. Sollum works closely with greenhouse producers, tailoring light recipes to match the growth cycles of various plants, regardless of their native climate or greenhouse location. This adaptive technology not only enhances energy efficiency and productivity but also improves produce quality, all while minimizing environmental impact.

Floating Point Group (FPG) is a prime brokerage specializing in cryptocurrency trading, designed to facilitate access to liquidity across diverse markets for advanced trading strategies. The company operates the largest global digital asset agency trading desk, collaborating with funds and blockchain foundations to ensure efficient trade execution. FPG provides a secure custodial solution that integrates trading, settlement, and yield functionalities, along with insurance for cryptocurrencies. Its trading infrastructure is engineered specifically for the cryptocurrency ecosystem, utilizing high-quality data to develop and optimize market-efficient execution algorithms. By streamlining the trading process, Floating Point Group enables traders to enhance their performance across multiple exchanges based on time, price, and order volume.

TATUM Bioscience is a synthetic biology startup focused on developing innovative synthetic advanced biologics designed to perform multiple therapeutic activities. The company aims to address diseases that conventional medications have struggled to treat by creating synthetic live biotherapeutic drugs. These biotherapeutics leverage probiotics with specialized modules to deliver unique therapeutic functions, effectively tackling various diseases and combating bacterial resistance to antibiotics. By providing a single-agent solution that incorporates the benefits of combination therapy, TATUM Bioscience seeks to offer safer and more efficient treatment options for patients facing challenges with existing drug therapies.

Botpress, Inc. is a company that specializes in creating an open-source chatbot development platform. Founded in 2016 and based in Newark, Delaware, Botpress offers a dual-license software solution that enables developers and organizations to build, deploy, and manage various types of chatbots, including scripted, artificial intelligence, and application-based bots. The platform features a conversational flow management system, natural language understanding, and extensive customization options, allowing businesses to create tailored conversational experiences for their customers. Botpress serves a diverse clientele, from individual developers to large enterprises, and has gained recognition as a leading provider in the open-source conversational assistant space.

Tornado operates a social investment discussion platform aimed at enhancing the skills and profitability of investors. The platform facilitates discussions among users and experts, allowing participants to share and learn investment ideas. By providing tools for portfolio allocation, Tornado enables users to make informed investment decisions tailored to their specific objectives. This approach transforms the investing experience into a more engaging and sophisticated process compared to traditional online brokerages. Tornado's focus on community-driven investment strategies aims to empower investors of all skill levels to improve their profitability and portfolio intelligence.

ORA is a Montreal-based startup working with advanced nano-materials to produce unparalleled audio experiences. Their team of sound engineers, chemists and material scientists work with the exciting properties of *Graphene* (the strongest and lightest material known to man) to deliver smaller/lighter, more energy efficient speakers, all while remarkably improving sound quality. With a simple drop-in replacement of the speaker’s membrane, GrapheneQ can 1) extend the battery life of a portable audio device by up to 70% b) generate up to 4x the volume and c) significantly reduce the overall size of the speaker, allowing for bigger batteries/thinner devices. ORA's technology is disrupting a technology that has seen little innovation since its invention in 1921: the loudspeaker!

InVivo AI is a Montreal-based company founded in 2017 that specializes in leveraging artificial intelligence to enhance pharmaceutical research and development, with a particular focus on preclinical toxicology. The company has developed advanced AI methods for molecular representation, structure and ligand-based de novo design, and multiparameter optimization, enabling the creation of novel chemistry to address complex biological challenges.

Ourly is a digital allowance platform for banks that provides tools to remove the friction that parents and kids struggle with regarding money matters. Their best-in-breed SaaS platform empowers financial institutions to “turn on” financial literacy as a youth banking solution – standalone or integrated.

Nomic is a bioengineering company focused on enhancing access to the human proteome, similar to the accessibility of the human genome. The company is developing the next-generation ELISA platform, known as nELISA, which is designed for high-throughput protein measurement. Nomic's solutions enable scientists to conduct protein profiling efficiently, allowing them to determine the scope and scale of their experiments. The platform features a cost-effective reagent system that integrates seamlessly with existing industry cytometers, facilitating high-throughput analysis and the creation of custom protein panels. By leveraging advanced technology, Nomic aims to empower researchers and nanotechnology developers to utilize DNA as a flexible and programmable linker, effectively addressing challenges such as cross-reactivity in protein measurements.

StreamingFast, founded by a team of experienced tech entrepreneurs, specializes in developing highly scalable open-source software designed for processing and indexing blockchain data. Based in Montreal, Canada, the company leverages its expertise in large-scale data science to create innovative solutions. Its flagship innovation, the Firehose, employs a file-based and streaming-first approach to handle blockchain data efficiently, facilitating high-performance indexing on high-throughput chains.

Nimble Science Ltd. is a digital health company focused on revolutionizing gastrointestinal (GI) health through its innovative SIMBA capsule technology. This end-to-end platform facilitates multi-omic mapping of the GI tract, allowing for the passive sampling of small bowel luminal fluid. By leveraging this advanced sampling method, Nimble Science provides precision datasets that offer valuable insights into GI health, thereby transforming the diagnosis and treatment of gastrointestinal conditions. The company's approach enables healthcare providers to directly sample and analyze targeted regions of the GI tract, marking a significant advancement in the understanding and management of GI health.

HumanFirst is the playground for prompt and data work. Experiment with raw data, surface business-specific insights, and build reliable AI workflows with speed, accuracy, and trust. With a low-code platform and enterprise-grade security posture, HumanFirst empowers enterprises to transform every team into AI experts.

Sollum Technologies Inc., established in 2015 and headquartered in Montreal, Canada, specializes in designing and manufacturing innovative lighting systems. The company's core product is a smart LED lighting solution that dynamically replicates the full spectrum of natural sunlight, optimizing growth conditions for crops and animals. Sollum works closely with greenhouse producers, tailoring light recipes to match the growth cycles of various plants, regardless of their native climate or greenhouse location. This adaptive technology not only enhances energy efficiency and productivity but also improves produce quality, all while minimizing environmental impact.

Seqera is a developer of workflow orchestration software that simplifies complex data analysis pipelines for life sciences research. The company's platform consolidates fragmented data and computing resources, allowing scientists to efficiently assemble and deploy scalable data analysis pipelines across multi-cloud environments. This capability enables researchers to tackle complex problems in genomics and global health, enhancing productivity and accelerating the pace of discovery. Trusted by over 150 leading organizations in the life sciences sector, Seqera's software empowers scientists to work with larger datasets and complete their analyses more quickly and confidently. Through its innovative approach, Seqera drives advancements in research and fosters collaboration within the scientific community.